Product Information
DOXEPIN HCL 3 MG TABLET is a generic product labeled by Archis Pharma LLC, priced at $1.3614 per EA under NDC 72819016103. Its NADAC has been published 202 times since Aug 17, 2022.
Strength
3 mg/1
Manufacturer
Archis Pharma LLCNDC
72819016103
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXEPIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202337On Market Since
2/21/2022
Pharmacological Classes
Price Statistics
The NADAC for DOXEPIN HCL 3 MG TABLET has been published 202 times since Aug 17, 2022, and over the history we have for it it has declined 83.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.3614 per EA |
|---|---|
| All-time high | $8.3729 (Sep 14, 2022) |
| All-time low | $1.3614 (Jun 17, 2026) |
| 52-week high | $2.1099 |
| 52-week low | $1.3614 |
| Median price | $3.7015 |
| Average price | $4.3849 |
| Largest weekly change | -32.6% (Sep 20, 2023) |
| Weeks tracked | 202 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOXEPIN HCL 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Archis Pharma LLC, is $1.3614 per EA (NDC 72819016103), effective Jun 24, 2026.
How has the price of DOXEPIN HCL 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 83.7%. It has been tracked across 202 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?
Since Aug 17, 2022, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3614 (Jun 17, 2026) to a high of $8.3729 (Sep 14, 2022), with a median of $3.7015 per EA.
Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as DOXEPIN HCL 3 MG TABLET, but none are currently priced below it.
Who manufactures DOXEPIN HCL 3 MG TABLET?
DOXEPIN HCL 3 MG TABLET (NDC 72819016103) is labeled by Archis Pharma LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification